# FDA Inspection 1107055 - Novartis Grimsby Limited - September 13, 2019

Source: https://www.keypedia.com/records/fda_inspections/novartis-grimsby-limited/ebbd58f2-d4eb-464e-8585-a2fca4baafd8
Source feed: FDA_Inspections

> FDA Inspection 1107055 for Novartis Grimsby Limited on September 13, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1107055
- Company Name: Novartis Grimsby Limited
- Inspection Date: 2019-09-13
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1017835 - 2017-06-09](https://www.keypedia.com/records/fda_inspections/novartis-grimsby-limited/af6260a8-4283-47c3-991b-a60f1a29d267)
- [FDA Inspection 924506 - 2015-04-24](https://www.keypedia.com/records/fda_inspections/novartis-grimsby-limited/57611952-dfaa-40e5-9a18-08b25888f024)
- [FDA Inspection 838830 - 2013-06-14](https://www.keypedia.com/records/fda_inspections/novartis-grimsby-limited/1c6d9038-3d7a-4ea3-a83c-1d36dd2b8f12)

Company: https://www.keypedia.com/companies/novartis-grimsby-limited/d203859b-892c-4307-a6de-7e6f3a881097

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c